1019. Deputy Sorca Clarke asked the Minister for Health the oversight mechanisms that are in place within CAMHS-ID to ensure that clinical decisions, particularly those involving the withdrawal of psychiatric medication in vulnerable children, are evidence-based, documented, and subject to review; and if she will outline any recent audits conducted in this area. [36676/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
1,267 questions match, newest first.
1020. Deputy Alan Kelly asked the Minister for Health the timeline for the creation of the new Limerick Hospital Development Board, which she said would be put in place following her announcement in March of a new hospital in Limerick for the mid-west region. [36720/26]
1021. Deputy Ken O'Flynn asked the Minister for Health the total monetary value of rejected or unpaid pharmacy claims under the General Medical Services Scheme attributable to administrative or submission errors in each year from 2020 to 2026, in tabular form. [36741/26]
1022. Deputy Ken O'Flynn asked the Minister for Health the most common categories of administrative or submission errors resulting in rejected or unpaid pharmacy claims under the general medical services scheme in 2024 and 2025 [36742/26]
1023. Deputy Ken O'Flynn asked the Minister for Health the average time taken to resolve and reimburse corrected pharmacy claims originally rejected due to administrative or submission errors. [36743/26]
1024. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the financial or operational impact of rejected pharmacy claims on independent community pharmacies. [36744/26]
1025. Deputy Ken O'Flynn asked the Minister for Health whether any national targets or key performance indicators exist to reduce the proportion of rejected or unpaid pharmacy claims attributable to administrative or submission errors. [36745/26]
1026. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has considered introducing additional automated pre-submission validation systems to reduce pharmacy claim rejection rates. [36746/26]
1027. Deputy Ken O'Flynn asked the Minister for Health the proportion of rejected pharmacy claims subsequently resubmitted successfully as corrected reclaims in each year from 2020 to 2026. [36747/26]
1028. Deputy Ken O'Flynn asked the Minister for Health whether any review has been undertaken into whether pharmacy software compatibility issues contribute disproportionately to rejected or unpaid claims. [36748/26]
1029. Deputy Ken O'Flynn asked the Minister for Health the financial impact on annual PCRS expenditure arising from the 2022 steri-neb salamol price uplift. [36753/26]
1030. Deputy Ken O'Flynn asked the Minister for Health the rationale and assessment process underpinning the 2022 reimbursement price uplift granted to Steri-neb Salamol 2.5mg/2.5ml. [36754/26]
1031. Deputy Ken O'Flynn asked the Minister for Health whether any cost-effectiveness, inflationary, supply-chain or market-availability assessment was undertaken prior to the Steri-neb Salamol price uplift. [36755/26]
1032. Deputy Ken O'Flynn asked the Minister for Health how many medicinal products received reimbursement price uplifts under PCRS arrangements in each year from 2020 to 2026. [36756/26]
1033. Deputy Ken O'Flynn asked the Minister for Health the estimated additional annual expenditure arising from reference pricing adjustments which increased reimbursement rates rather than reduced them. [36757/26]
1034. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE publishes any annual review of reimbursement price uplifts and their impact on medicines expenditure. [36758/26]
1035. Deputy Ken O'Flynn asked the Minister for Health whether pharmacies or representative bodies are formally consulted before reimbursement rule changes or reference pricing adjustments are introduced. [36759/26]
1036. Deputy Ken O'Flynn asked the Minister for Health the total expenditure by each individual hospital and hospital group on private ambulance services in each year from 2020 to date in 2026, in tabular form. [36778/26]
1037. Deputy Ken O'Flynn asked the Minister for Health whether any national procurement framework exists governing the engagement of private ambulance providers by HSE-funded hospitals. [36779/26]
1038. Deputy Ken O'Flynn asked the Minister for Health whether all private ambulance providers contracted by HSE-funded hospitals are required to meet specified national clinical governance and patient safety standards. [36780/26]
1039. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE maintains any register of private ambulance providers engaged by publicly funded hospitals. [36781/26]
1040. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been carried out regarding the impact of reliance on private ambulance services on continuity of care, patient safety, or response times. [36782/26]
1041. Deputy Ken O'Flynn asked the Minister for Health the number of additional National Ambulance Service intermediate care staff and vehicles projected to be required nationally to eliminate reliance on private ambulance providers. [36783/26]
1042. Deputy Ken O'Flynn asked the Minister for Health whether any review has been undertaken into regional variation in the use of private ambulance providers by hospitals or hospital groups. [36784/26]
1043. Deputy Ken O'Flynn asked the Minister for Health whether any private ambulance providers currently engaged by HSE-funded hospitals also provide services under other HSE contracts or public procurement arrangements. [36785/26]